Walter Dennis Kohut, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1511 Westover Ter, Suite 201, Greensboro, NC 27408 Phone: 336-533-4192 Fax: 336-533-0866 |
Stephen Alan South, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2703 Henry St, Greensboro, NC 27405 Phone: 336-621-8911 Fax: 336-621-6322 |
Dr. Bindubal Balan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1511 Westover Ter, Suite 201, Greensboro, NC 27408 Phone: 336-533-4192 Fax: 336-533-0866 |
Dr. Cristina Gherghe, MD, PHD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 301 E Wendover Ave Ste 211, Greensboro, NC 27401 Phone: 336-832-3088 Fax: 336-832-3080 |
Dr. Ajay Kumar, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 301 E Wendover Ave Ste 211, Greensboro, NC 27401 Phone: 336-832-3088 Fax: 336-832-3080 |
News Archive
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.
Scientists have known since the 1980s that many cancer cells are relatively sensitive to the deprivation of an essential amino acid known as methionine. It has, however, long been unclear what causes such marked dependency on methionine.
Ambulances with specialized staff and equipment to provide rapid stroke treatment report financial difficulties due to limited reimbursement from health care insurers, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.
Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer - marking a new era of research into personalised medicines to treat cancer.
Following the reports from different countries of patients recovered from coronavirus disease (COVID-19) but testing positive again during the control diagnostic appraisal, South Korea's Centers for Disease Control and Prevention (CDC) documents a similar occurrence in 51 patients.
› Verified 4 days ago